Elanco Animal Health, Inc. (ELAN)
23.55
+0.01
(+0.04%)
USD |
NYSE |
Oct 16, 16:00
23.56
+0.01
(+0.04%)
After-Hours: 20:00
Elanco Animal Health Cash from Investing (Quarterly) : -110.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -110.00M |
| March 31, 2026 | -60.00M |
| December 31, 2025 | -64.00M |
| September 30, 2025 | -101.00M |
| June 30, 2025 | -56.00M |
| March 31, 2025 | -58.00M |
| December 31, 2024 | -90.00M |
| September 30, 2024 | 1.244B |
| June 30, 2024 | -33.00M |
| March 31, 2024 | 37.00M |
| December 31, 2023 | -35.00M |
| September 30, 2023 | -36.00M |
| June 30, 2023 | -43.00M |
| March 31, 2023 | -55.00M |
| December 31, 2022 | -76.00M |
| September 30, 2022 | -37.00M |
| June 30, 2022 | -37.00M |
| Date | Value |
|---|---|
| March 31, 2022 | -29.00M |
| December 31, 2021 | -74.00M |
| September 30, 2021 | -441.00M |
| June 30, 2021 | -25.00M |
| March 31, 2021 | 10.00M |
| December 31, 2020 | -73.30M |
| September 30, 2020 | -4.697B |
| June 30, 2020 | 10.60M |
| March 31, 2020 | -19.60M |
| December 31, 2019 | -74.30M |
| September 30, 2019 | -83.00M |
| June 30, 2019 | -49.00M |
| March 31, 2019 | -28.50M |
| December 31, 2018 | -48.10M |
| September 30, 2018 | -21.40M |
| June 30, 2018 | -23.10M |
| March 31, 2018 | -34.40M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zoetis, Inc. | -300.00M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Eli Lilly & Co. | -15.40B |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 277.00M |
| Cash from Financing (Quarterly) | -74.00M |
| Free Cash Flow | 379.00M |
| Free Cash Flow Per Share (Quarterly) | 0.4823 |
| Free Cash Flow to Equity (Quarterly) | 317.00M |
| Free Cash Flow to Firm (Quarterly) | 307.64M |
| Free Cash Flow Yield | 3.21% |